APA-viite (7. p.)

Nikula, T. (2022). Development of radiolabeled monoclonal antibody constructs: Capable of transporting high radiation dose into cancer cells.

Chicago-viite (17. p.)

Nikula, Tuomo. Development of Radiolabeled Monoclonal Antibody Constructs: Capable of Transporting High Radiation Dose into Cancer Cells. [Jyväskylä], 2022.

MLA-viite (9. p.)

Nikula, Tuomo. Development of Radiolabeled Monoclonal Antibody Constructs: Capable of Transporting High Radiation Dose into Cancer Cells. 2022.